Evaluation of a hepatitis B vaccination program in Chiang Mai, Thailand.
dc.contributor.author | Jutavijittum, Prapan | en_US |
dc.contributor.author | Jiviriyawat, Yupa | en_US |
dc.contributor.author | Yousukh, Amnat | en_US |
dc.contributor.author | Hayashi, Shigeki | en_US |
dc.contributor.author | Toriyama, Kan | en_US |
dc.date.accessioned | 2009-05-27T15:08:37Z | |
dc.date.available | 2009-05-27T15:08:37Z | |
dc.date.issued | 2005-01-24 | en_US |
dc.description | The Southeast Asian Journal of Tropical Medicine and Public Health. | en_US |
dc.description.abstract | Chiang Mai is a province in northern Thailand that started a vaccination program for hepatitis B virus (HBV) infection in 1989. In this paper, we report the long-term efficacy of this program. Of children aged 4-9 years, 65.7% had a complete course and 3.8% had an incomplete vaccination course. Urban schoolchildren had higher percentage of HB vaccination than rural schoolchildren (89.1% vs 46.9% for the complete course, p < 0.001). The overall prevalence rate of HBsAg in Chiang Mai schoolchildren was 1.2%, with no significant differences between gender (p = 0.496) and school areas (p = 0.477). Anti-HBc antibodies were detected in 6.9% of children. Overall, 26.2% of children had protective levels of anti-HBs antibodies (> 10.0 mlU/ml), and 11.2% had low levels of these antibodies (1.0-9.9 mlU/ml). Compared to previous reports, our results show a lower percentage of anti-HBs antibodies, 33.8% of children age 4 years had protective anti-HBs antibodies, dropping to 18.4% by age 9 years. Among those anti-HBs seropositive, 9.1% were anti-HBc positive, indicating a natural infection with HBV. We found a small number of children, despite adequate immunization, developed HBV infection. | en_US |
dc.description.affiliation | Department of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand. pjutavij@mail.med.cmu.ac.th | en_US |
dc.identifier.citation | Jutavijittum P, Jiviriyawat Y, Yousukh A, Hayashi S, Toriyama K. Evaluation of a hepatitis B vaccination program in Chiang Mai, Thailand. The Southeast Asian Journal of Tropical Medicine and Public Health. 2005 Jan; 36(1): 207-12 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/32025 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.tm.mahidol.ac.th/seameo/2005_36_1/35-3376.pdf | en_US |
dc.subject.mesh | Antibodies, Viral --blood | en_US |
dc.subject.mesh | Child | en_US |
dc.subject.mesh | Child, Preschool | en_US |
dc.subject.mesh | Endemic Diseases --prevention & control | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Hepatitis B --epidemiology | en_US |
dc.subject.mesh | Hepatitis B Vaccines --supply & distribution | en_US |
dc.subject.mesh | Hepatitis B virus --immunology | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Immunization Programs --standards | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Prevalence | en_US |
dc.subject.mesh | Program Evaluation | en_US |
dc.subject.mesh | Rural Health | en_US |
dc.subject.mesh | Thailand --epidemiology | en_US |
dc.subject.mesh | Treatment Outcome | en_US |
dc.subject.mesh | Urban Health | en_US |
dc.title | Evaluation of a hepatitis B vaccination program in Chiang Mai, Thailand. | en_US |
dc.type | Evaluation Studies | en_US |
dc.type | Journal Article | en_US |
dc.type | Research Support, Non-U.S. Gov't | en_US |